Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-05-29

Clinical Trial Update: Irbesartan and Adhesion Molecules in AF [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining the effects of irbesartan on adhesion molecules in patients with atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Irbesartan (irbesartan)

Snippet

Sponsor: University of Magdeburg | Conditions: Persistent Atrial Fibrillation | Phase 4 | Status: UNKNOWN